Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health
CCR - For Our Staff| Home |

Our Science – Anderson Website

Stephen K. Anderson, Ph.D.

Selected Publications

1)  Wright PW, Huehn A, Cichocki F, Li H, Sharma N, Dang H, Lenvik TR, Woll P, Kaufman D, Miller JS, Anderson SK.
Identification of a KIR antisense lncRNA expressed by progenitor cells.
Genes Immun. 14: 427-33, 2013.
2)  Cichocki F, Lenvik T, Sharma N, Yun G, Anderson SK, Miller JS.
Cutting edge: KIR antisense transcripts are processed into a 28-base PIWI-like RNA in human NK cells.
J. Immunol. 185: 2009-12, 2010.
3)  Li H, Pascal V, Martin MP, Carrington M, Anderson SK.
Genetic control of variegated KIR gene expression: polymorphisms of the bi-directional KIR3DL1 promoter are associated with distinct frequencies of gene expression.
PLoS Genet. 4: e1000254, 2008.
4)  Davies GE, Locke SM, Wright PW, Li H, Hanson RJ, Miller JS, Anderson SK.
Identification of bidirectional promoters in the human KIR genes.
Genes Immun. 8: 245-53, 2007.
5)  Saleh A, Davies GE, Pascal V, Wright PW, Hodge DL, Cho EH, Lockett SJ, Abshari M, Anderson SK.
Identification of probabilistic transcriptional switches in the Ly49 gene cluster: a eukaryotic mechanism for selective gene activation.
Immunity. 21: 55-66, 2004.
6)  Felices M, Lenvik TR, Ankarlo DE, Foley B, Curtsinger J, Luo X, Blazar BR, Anderson SK, Miller JS.
Functional NK Cell Repertoires Are Maintained through IL-2Ra and Fas Ligand.
J. Immunol. 192: 3889-97, 2014.
7)  O'Connor GM, Vivian JP, Widjaja JM, Bridgeman JS, Gostick E, Lafont BA, Anderson SK, Price DA, Brooks AG, Rossjohn J, McVicar DW.
Mutational and structural analysis of KIR3DL1 reveals a lineage-defining allotypic dimorphism that impacts both HLA and peptide sensitivity.
J. Immunol. 192: 2875-84, 2014.
8)  Cichocki F, Schlums H, Li H, Stache V, Holmes T, Lenvik TR, Chiang SC, Miller JS, Meeths M, Anderson SK, Bryceson YT.
Transcriptional regulation of Munc13-4 expression in cytotoxic lymphocytes is disrupted by an intronic mutation associated with a primary immunodeficiency.
J. Exp. Med. 2014.
9)  Alvarez M, Sungur CM, Ames E, Anderson SK, Pomeroy C, Murphy WJ.
Contrasting effects of anti-Ly49A due to MHC class I cis binding on NK cell-mediated allogeneic bone marrow cell resistance.
J. Immunol. 191: 688-98, 2013.
10)  Barao I, Wright PW, Sungur CM, Anderson SK, Redelman D, Murphy WJ.
Differential Expression of the Ly49G(B6), but Not the Ly49G(BALB), Receptor Isoform during Natural Killer Cell Reconstitution after Hematopoietic Stem Cell Transplantation.
Biol. Blood Marrow Transplant. 19: 1446-52, 2013.
Click Here to View Expanded Bibliography.

This page was last updated on 6/16/2014.